The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leukemia, Myeloid, Chronic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukemia, Myeloid, Chronic


Psychiatry related information on Leukemia, Myeloid, Chronic


High impact information on Leukemia, Myeloid, Chronic


Chemical compound and disease context of Leukemia, Myeloid, Chronic


Biological context of Leukemia, Myeloid, Chronic


Anatomical context of Leukemia, Myeloid, Chronic


Gene context of Leukemia, Myeloid, Chronic


Analytical, diagnostic and therapeutic context of Leukemia, Myeloid, Chronic


  1. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. Koller, C.A., Miller, D.M. N. Engl. J. Med. (1986) [Pubmed]
  2. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. Druker, B.J., Sawyers, C.L., Kantarjian, H., Resta, D.J., Reese, S.F., Ford, J.M., Capdeville, R., Talpaz, M. N. Engl. J. Med. (2001) [Pubmed]
  3. Letter: Translocation of the Philadelphia chromosome onto the 17 short arm in chronic myeloid leukemia: a second example. Engle, E., McGee, B.J., Flexner, J.M., Krantz, S.B. N. Engl. J. Med. (1975) [Pubmed]
  4. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. Yasuda, T., Shirakata, M., Iwama, A., Ishii, A., Ebihara, Y., Osawa, M., Honda, K., Shinohara, H., Sudo, K., Tsuji, K., Nakauchi, H., Iwakura, Y., Hirai, H., Oda, H., Yamamoto, T., Yamanashi, Y. J. Exp. Med. (2004) [Pubmed]
  5. Cytotoxicity of antisera to a myelogenous leukemia cell line with the Philadelphia chromosome. Whitson, M.E., Lozzio, C.B., Lozzio, B.B., Wust, C.J., Sonoda, T., Avery, B. J. Natl. Cancer Inst. (1976) [Pubmed]
  6. Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia. Moravcová, J., Nádvorníková, S., Lukásová, M., Klamová, H. Blood (1999) [Pubmed]
  7. The BCR-ABL story: bench to bedside and back. Wong, S., Witte, O.N. Annu. Rev. Immunol. (2004) [Pubmed]
  8. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Korsmeyer, S.J. Annu. Rev. Immunol. (1992) [Pubmed]
  9. Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. Azam, M., Latek, R.R., Daley, G.Q. Cell (2003) [Pubmed]
  10. Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. Goldman, J.M., Melo, J.V. N. Engl. J. Med. (2001) [Pubmed]
  11. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Carpino, N., Wisniewski, D., Strife, A., Marshak, D., Kobayashi, R., Stillman, B., Clarkson, B. Cell (1997) [Pubmed]
  12. Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin. Fefer, A., Cheever, M.A., Thomas, E.D., Boyd, C., Ramberg, R., Glucksberg, H., Buckner, C.D., Storb, R. N. Engl. J. Med. (1979) [Pubmed]
  13. Interferon alfa-2b and cytarabine in chronic myelogenous leukemia. Patel, T., Roychowdhury, D.F. N. Engl. J. Med. (1997) [Pubmed]
  14. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study. Marks, S.M., Baltimore, D., McCaffrey, R. N. Engl. J. Med. (1978) [Pubmed]
  15. Isotretinoin for juvenile chronic myelogenous leukemia. Donadieu, J. N. Engl. J. Med. (1995) [Pubmed]
  16. Specific targeted therapy of chronic myelogenous leukemia with imatinib. Deininger, M.W., Druker, B.J. Pharmacol. Rev. (2003) [Pubmed]
  17. c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. Groffen, J., Heisterkamp, N., Stephenson, J.R., van Kessel, A.G., de Klein, A., Grosveld, G., Bootsma, D. J. Exp. Med. (1983) [Pubmed]
  18. Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha. Bhatia, R., McGlave, P.B., Verfaillie, C.M. J. Clin. Invest. (1995) [Pubmed]
  19. Functional maturation of membrane potential changes and superoxide-producing capacity during differentiation of human granulocytes. Kitagawa, S., Ohta, M., Nojiri, H., Kakinuma, K., Saito, M., Takaku, F., Miura, Y. J. Clin. Invest. (1984) [Pubmed]
  20. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M., Hirai, H. EMBO J. (1994) [Pubmed]
  21. Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase. Skorski, T., Nieborowska-Skorska, M., Wlodarski, P., Perrotti, D., Martinez, R., Wasik, M.A., Calabretta, B. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  22. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. Li, S., Ilaria, R.L., Million, R.P., Daley, G.Q., Van Etten, R.A. J. Exp. Med. (1999) [Pubmed]
  23. In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen. Correale, P., Walmsley, K., Nieroda, C., Zaremba, S., Zhu, M., Schlom, J., Tsang, K.Y. J. Natl. Cancer Inst. (1997) [Pubmed]
  24. BCR/ABL induces multiple abnormalities of cytoskeletal function. Salgia, R., Li, J.L., Ewaniuk, D.S., Pear, W., Pisick, E., Burky, S.A., Ernst, T., Sattler, M., Chen, L.B., Griffin, J.D. J. Clin. Invest. (1997) [Pubmed]
  25. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia. Cannistra, S.A., Herrmann, F., Davis, R., Nichols, K., Griffin, J.D. J. Clin. Invest. (1986) [Pubmed]
  26. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. Verfaillie, C.M., McCarthy, J.B., McGlave, P.B. J. Clin. Invest. (1992) [Pubmed]
  27. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Reuther, J.Y., Reuther, G.W., Cortez, D., Pendergast, A.M., Baldwin, A.S. Genes Dev. (1998) [Pubmed]
  28. A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. Turcotte, K., Gauthier, S., Tuite, A., Mullick, A., Malo, D., Gros, P. J. Exp. Med. (2005) [Pubmed]
  29. Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines. Zhang, Y.Y., Vik, T.A., Ryder, J.W., Srour, E.F., Jacks, T., Shannon, K., Clapp, D.W. J. Exp. Med. (1998) [Pubmed]
  30. A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo. Okuda, K., D'Andrea, A., Etten, R.A., Griffin, J.D. J. Clin. Invest. (1997) [Pubmed]
  31. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Dash, A.B., Williams, I.R., Kutok, J.L., Tomasson, M.H., Anastasiadou, E., Lindahl, K., Li, S., Van Etten, R.A., Borrow, J., Housman, D., Druker, B., Gilliland, D.G. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  32. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. Klejman, A., Schreiner, S.J., Nieborowska-Skorska, M., Slupianek, A., Wilson, M., Smithgall, T.E., Skorski, T. EMBO J. (2002) [Pubmed]
  33. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Buño, I., Wyatt, W.A., Zinsmeister, A.R., Dietz-Band, J., Silver, R.T., Dewald, G.W. Blood (1998) [Pubmed]
  34. Serial in vitro bone marrow fibroblast culture in human leukemia. Nagao, T., Yamauchi, K., Komatsuda, M. Blood (1983) [Pubmed]
  35. A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients. Testoni, N., Martinelli, G., Farabegoli, P., Zaccaria, A., Amabile, M., Raspadori, D., Pelliconi, S., Zuffa, E., Carboni, C., Tura, S. Blood (1996) [Pubmed]
  36. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Graham, S.M., Jørgensen, H.G., Allan, E., Pearson, C., Alcorn, M.J., Richmond, L., Holyoake, T.L. Blood (2002) [Pubmed]
WikiGenes - Universities